Get started
Author

Simon Englund

Observed names: Englund, Simon, S. Englund
ORCID: 0000-0002-1042-4400
Observed ORCID: 0000-0002-1042-4400
OpenAlex ID: A5032031992
High-intensity resistance training in people with multiple sclerosis experiencing fatigue: A randomised controlled trial
2022 · S. Englund, F. Piehl, et al. · Multiple Sclerosis and Related Disorders · 34
COMBAT ‐ MS : A Population‐Based Observational Cohort Study Addressing the Benefit–Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab
2024 · Fredrik Piehl, Peter Alping, et al. · Annals of Neurology · 30
PDF
Risk of depression in multiple sclerosis across disease-modifying therapies
2021 · Elisa Longinetti, Thomas Frisell, et al. · Multiple Sclerosis Journal · 26
Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study
2023 · Katharina Fink, Agnes Gorczyca, et al. · Multiple Sclerosis Journal · 17
COVID ‐19 clinical outcomes and DMT of MS patients and population‐based controls
2022 · Elisa Longinetti, Hannah Bower, et al. · Annals of Clinical and Translational Neurology · 17
PDF
Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohort
2022 · Simon Englund, Marie Kierkegaard, et al. · Multiple Sclerosis and Related Disorders · 13
Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy
2023 · Elisa Longinetti, Simon Englund, et al. · Journal of Neurology Neurosurgery & Psychiatry · 12
PDF
Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons With Multiple Sclerosis in Sweden
2021 · Kyla A. McKay, Fredrik Piehl, et al. · JAMA Network Open · 11
PDF
Can health behaviours prolong survival and compress the period of survival with the disability? A population-based cohort study
2020 · Wei Wu, Weili Xu, et al. · Age and Ageing · 8
PDF
Trajectories of self-reported fatigue following initiation of multiple sclerosis disease-modifying therapy
2024 · Simon Englund, Thomas Frisell, et al. · Journal of Neurology Neurosurgery & Psychiatry · 6
PDF
Comparing the Safety and Effectiveness of Different Medicines to Treat Multiple Sclerosis – The COMBAT-MS Study
2023 · Fredick Piehl, Anna Fogdell-Hahn, et al. · 1
PDF
Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss
2025 · Simon Englund, Johan Reutfors, et al. · Annals of Clinical and Translational Neurology
PDF
Predictors and treatment of fatigue in multiple sclerosis
2025 · Simon Englund
PDF
Predictors and treatment of fatigue in multiple sclerosis
2025 · Simon Englund
Comparing the Safety of Medicines to Treat MS during the COVID-19 Pandemic
2023 · Fredrick Piehl, Anna Fogdell-Hahn, et al.
PDF
COVID-19–Related Enhancement for the COMBAT-MS Study
2023 · Fredrik Piehl, Anna Fogdell-Hahn, et al.
Works count: 24
Citation count: 175
H-index: 8
I10-index: 8
Year
Topic
Type